What Researchers Did
Researchers conducted a prospective study to evaluate hyperbaric oxygen treatment for 40 patients with severe haemorrhagic radiation cystitis.
What They Found
Haematuria completely disappeared or improved in 37 of 40 patients (92.5%) after hyperbaric oxygen treatment. The mean follow-up was 23.1 months, with a low recurrence rate of 0.12 per year and no reported adverse effects.
What This Means for Canadian Patients
Canadian patients suffering from severe radiation-induced haemorrhagic cystitis may find hyperbaric oxygen treatment to be an effective option for reducing or eliminating haematuria. This treatment could offer a non-invasive approach to manage a condition that is otherwise difficult to treat.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation of this prospective study is the absence of a control group, which prevents direct comparison with other treatments or no treatment.